Showing results (231-240 of 389) with videos related to
Sort By:
Pageof 39
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 5, 2011
S-1 plus cisplatin with concurrent radiotherapy for locally advanced non-small cell lung cancer: a multi-institutional phase II trial (West Japan Thoracic Oncology Group 3706)Yukito Ichinose, Takashi Seto, Tomonari Sasaki, et al.Lung Cancer (Amsterdam, Netherlands)|December 19, 2020
Clinical utility of pretreatment Glasgow prognostic score in non-small-cell lung cancer patients treated with immune checkpoint inhibitorsShinkichi Takamori, Kazuki Takada, Mototsugu Shimokawa, et al.Journal of Cachexia, Sarcopenia and Muscle|March 11, 2023
Epidemiology, risk factors and impact of cachexia on patient outcome: Results from the Japanese Lung Cancer Registry StudyTakehito Shukuya, Kazuhisa Takahashi, Yasushi Shintani, et al.Journal of Epidemiology|December 3, 2023
Risks of Dementia in a General Japanese Older Population With Preserved Ratio Impaired Spirometry: The Hisayama StudyKenji Kawatoko, Yasuyoshi Washio, Tomoyuki Ohara, et al.Lung Cancer (Amsterdam, Netherlands)|February 9, 2025
Survival benefit and potential markers of chemotherapy for elderly and poor performance status patients with advanced non-small cell lung cancer: Results from the Japanese Joint Committee of lung cancer registry databaseSatoshi Ikeda, Takashi Ogura, Etsuo Miyaoka, et al.Annals of Surgical Oncology|March 1, 2019
Prognostic Impact of Programmed Death-Ligand 2 Expression in Primary Lung Adenocarcinoma PatientsShinkichi Takamori, Kazuki Takada, Koichi Azuma, et al.BMC Cancer|March 30, 2022
Efficacy of platinum agents for stage III non-small-cell lung cancer following platinum-based chemoradiotherapy: a retrospective studyEriko Miyawaki, Hirotsugu Kenmotsu, Yasushi Shintani, et al.Lung Cancer (Amsterdam, Netherlands)|June 17, 2020
Survival and prognostic factors in elderly patients receiving second-line chemotherapy for relapsed small-cell lung cancer: Results from the Japanese Joint Committee of Lung Cancer RegistrySatoshi Igawa, Katsuhiko Naoki, Yasushi Shintani, et al.Cancer Science|August 11, 2023
MicroRNA-326 negatively regulates CD155 expression in lung adenocarcinomaTakayuki Nakanishi, Yasuto Yoneshima, Koji Okamura, et al.Clinical Lung Cancer|May 9, 2020
Treatment Rationale and Design for APPLE (WJOG11218L): A Multicenter, Open-Label, Randomized Phase 3 Study of Atezolizumab and Platinum/Pemetrexed With or Without Bevacizumab for Patients With Advanced Nonsquamous Non-Small-Cell Lung CancerYoshimasa Shiraishi, Junji Kishimoto, Kentaro Tanaka, et al.Pageof 39